• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像在局部晚期宫颈癌宫旁侵犯定量评估及其与预后的关系:“PLACE”研究。

The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the "PLACE" study.

机构信息

Dipartimento Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Fondazione Policlinico Universitario A. Gemelli IRCCS, Research core facility Data Collection G-STeP, Rome, Italy.

出版信息

Eur Radiol. 2024 Jun;34(6):4003-4013. doi: 10.1007/s00330-023-10443-3. Epub 2023 Nov 20.

DOI:10.1007/s00330-023-10443-3
PMID:37981591
Abstract

OBJECTIVE

This retrospective observational study aims to evaluate the association between the extent of parametrial invasion (PMI) and disease-free survival (DFS) and cancer-specific survival (CSS) in patients with locally advanced cervical cancer (LACC).

MATERIALS AND METHODS

This study included patients with LACC showing parametrial invasion at Magnetic Resonance Imaging (MRI). They were treated with neoadjuvant chemo-radiotherapy (CT/RT) before undergoing radical hysterectomy. The staging MRIs were reviewed retrospectively. Measurements of maximum PMI (PMI) and parametrial length were taken bilaterally. After that, PMI was calculated by dividing PMI by parametrial length. Analysis was conducted on homogeneous subsets of patients, grouped based on their pathological lymph nodal evaluation (N- and N+). Correlations between PMI and PMI with DFS and CSS were evaluated in both the N- and N+ groups, employing univariable Cox regression analysis.

RESULTS

Out of 221 patients, 126 (57%) had non-metastatic lymph nodes (N-), while 95 (43%) had metastatic lymph nodes (N+). The median observation period for all these patients was 73 months (95% confidence interval [CI]: 66-77). The 5-year DFS and CSS probability rates were 75% and 85.7%, respectively, for the N- group and 54.3% and 73.6%, respectively, for the N+ group. A higher PMI (hazard ratio [HR] = 1.09) and PMI (HR = 1.04) correlated with worse overall survival in patients in the N- group (p = 0.025 and p = 0.042). These parameters did not show a significant statistical association in the N+ group.

CONCLUSIONS

The degree of PMI evaluated on MRI affects outcome in N- patients with LACC.

CLINICAL RELEVANCE STATEMENT

The degree of MRI parametrial invasion affects disease-free survival and cancer-specific survival in patients with the International Federation of Gynecology and Obstetrics (FIGO) stage IIB cervical cancer. This MRI finding can be easily incorporated into routine clinical practice.

KEY POINTS

• Visual assessment of parametrial invasion on MRI was not significantly associated with prognosis in locally advanced cervical cancer (LACC). • A greater degree of parametrial invasion is associated with poorer disease-free survival and cancer-specific survival in patients with LACC without metastatic lymph node involvement. • The degree of parametrial invasion at MRI has no correlation with prognosis in LACC with metastatic lymph nodes.

摘要

目的

本回顾性观察研究旨在评估局部晚期宫颈癌(LACC)患者宫旁侵犯程度(PMI)与无病生存(DFS)和癌症特异性生存(CSS)之间的关系。

材料与方法

本研究纳入了 MRI 显示宫旁侵犯的 LACC 患者。他们在接受根治性子宫切除术前行新辅助放化疗(CT/RT)。回顾性审查分期 MRI。双侧测量最大 PMI(PMI)和宫旁长度。然后,通过将 PMI 除以宫旁长度来计算 PMI。根据病理淋巴结评估(N-和 N+)将患者分为同质亚组进行分析。在 N-和 N+组中,采用单变量 Cox 回归分析评估 PMI 与 DFS 和 CSS 的相关性。

结果

在 221 名患者中,126 名(57%)患者无转移性淋巴结(N-),95 名(43%)患者有转移性淋巴结(N+)。所有这些患者的中位观察期为 73 个月(95%置信区间 [CI]:66-77)。N-组的 5 年 DFS 和 CSS 概率分别为 75%和 85.7%,N+组分别为 54.3%和 73.6%。在 N-组中,较高的 PMI(风险比 [HR] = 1.09)和 PMI(HR = 1.04)与总体生存率较差相关(p = 0.025 和 p = 0.042)。这些参数在 N+组中没有显示出统计学上的显著关联。

结论

MRI 上评估的 PMI 程度影响 LACC 中 N-患者的结局。

临床相关性声明

国际妇产科联合会(FIGO)分期 IIB 宫颈癌患者 MRI 宫旁侵犯程度影响无病生存率和癌症特异性生存率。这种 MRI 发现可以很容易地纳入常规临床实践。

关键点

• MRI 上宫旁侵犯的视觉评估与局部晚期宫颈癌(LACC)的预后无显著相关性。• 宫旁侵犯程度较大与无转移性淋巴结受累的 LACC 患者无病生存率和癌症特异性生存率较差相关。• MRI 上宫旁侵犯程度与转移性淋巴结的 LACC 患者的预后无相关性。

相似文献

1
The value of MRI in quantification of parametrial invasion and association with prognosis in locally advanced cervical cancer: the "PLACE" study.磁共振成像在局部晚期宫颈癌宫旁侵犯定量评估及其与预后的关系:“PLACE”研究。
Eur Radiol. 2024 Jun;34(6):4003-4013. doi: 10.1007/s00330-023-10443-3. Epub 2023 Nov 20.
2
How often parametrial involvement leads to post-operative adjuvant treatment in locally advanced cervical cancer after neoadjuvant chemotherapy and type C radical hysterectomy?在新辅助化疗和C型根治性子宫切除术后,局部晚期宫颈癌中宫旁组织受累导致术后辅助治疗的频率有多高?
Eur J Surg Oncol. 2015 Aug;41(8):1089-96. doi: 10.1016/j.ejso.2015.03.228. Epub 2015 Apr 7.
3
Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.临床 IIB 期宫颈癌病理性宫旁浸润的预测因素。
Eur J Surg Oncol. 2019 Aug;45(8):1417-1424. doi: 10.1016/j.ejso.2019.02.019. Epub 2019 Feb 18.
4
Radical hysterectomy for FIGO stage IIB cervical cancer: clinicopathological characteristics and prognostic evaluation.FIGO IIB期宫颈癌根治性子宫切除术:临床病理特征及预后评估
Gynecol Oncol. 2009 Jul;114(1):69-74. doi: 10.1016/j.ygyno.2009.03.026. Epub 2009 Apr 26.
5
A Predictive Model for Parametrial Invasion in Patients With FIGO Stage IB Cervical Cancer: Individualized Approach for Primary Treatment.FIGO IB期宫颈癌患者宫旁浸润的预测模型:个体化的初始治疗方法
Int J Gynecol Cancer. 2016 Jan;26(1):184-91. doi: 10.1097/IGC.0000000000000560.
6
Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.淋巴结阴性Ⅰ期-ⅡA 期宫颈癌根治性子宫切除术后无病生存预测的术后列线图。
J Obstet Gynaecol. 2020 Jul;40(5):699-704. doi: 10.1080/01443615.2019.1652888. Epub 2019 Oct 12.
7
Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?对于局部晚期宫颈癌患者,是否有进行范围较小的根治性手术的空间?
Gynecol Oncol. 2001 Nov;83(2):319-24. doi: 10.1006/gyno.2001.6393.
8
Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.接受根治性子宫切除术和系统性腹膜后淋巴结清扫术治疗的浸润性宫颈癌组织病理学预后因素的多变量分析。
Acta Obstet Gynecol Scand. 2002 Dec;81(12):1144-51. doi: 10.1034/j.1600-0412.2002.811208.x.
9
Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy.机器学习应用于磁共振成像评估,以检测接受新辅助化疗的局部晚期宫颈癌患者的淋巴结转移情况。
Arch Gynecol Obstet. 2023 Jun;307(6):1911-1919. doi: 10.1007/s00404-022-06824-6. Epub 2022 Nov 12.
10
Diagnostic performance of MR imaging in evaluating prognostic factors in patients with cervical cancer: a meta-analysis.磁共振成像在评估宫颈癌患者预后因素中的诊断性能:一项荟萃分析。
Eur Radiol. 2020 Mar;30(3):1405-1418. doi: 10.1007/s00330-019-06461-9. Epub 2019 Nov 27.

本文引用的文献

1
Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review.比较局部晚期宫颈癌的全球治疗指南以优化最佳护理实践:一项系统和范围界定综述。
Gynecol Oncol. 2022 Nov;167(2):360-372. doi: 10.1016/j.ygyno.2022.08.013. Epub 2022 Sep 10.
2
Detection of parametrial invasion in women with uterine cervical cancer using diffusion tensor imaging at 1.5T MRI.1.5T MRI 扩散张量成像检测子宫颈癌患者宫旁侵犯。
Diagn Interv Imaging. 2022 Oct;103(10):472-478. doi: 10.1016/j.diii.2022.05.005. Epub 2022 May 28.
3
Cervical Cancer Recurrence and Patient Survival After Radical Hysterectomy Followed by Either Adjuvant Chemotherapy or Adjuvant Radiotherapy With Optional Concurrent Chemotherapy: A Systematic Review and Meta-Analysis.
根治性子宫切除术后辅助化疗或辅助放疗加选择性同步化疗后的宫颈癌复发及患者生存率:一项系统评价和荟萃分析
Front Oncol. 2022 Mar 4;12:823064. doi: 10.3389/fonc.2022.823064. eCollection 2022.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: systematic review and meta-analysis.常规和先进影像学方法在评估新诊断宫颈癌中的诊断性能:系统评价和荟萃分析。
Eur Radiol. 2020 Oct;30(10):5560-5577. doi: 10.1007/s00330-020-06909-3. Epub 2020 May 15.
6
The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer.局部晚期宫颈癌患者同步放化疗后行辅助性子宫切除术的作用。
Int J Clin Oncol. 2020 Feb;25(2):384-390. doi: 10.1007/s10147-019-01551-6. Epub 2019 Sep 24.
7
Predictors for pathological parametrial invasion in clinical stage IIB cervical cancer.临床 IIB 期宫颈癌病理性宫旁浸润的预测因素。
Eur J Surg Oncol. 2019 Aug;45(8):1417-1424. doi: 10.1016/j.ejso.2019.02.019. Epub 2019 Feb 18.
8
Adjuvant Hysterectomy in Patients With Residual Disease After Radiation for Locally Advanced Cervical Cancer: A Prospective Longitudinal Study.局部晚期宫颈癌放疗后残留病灶患者的辅助性子宫切除术:一项前瞻性纵向研究。
J Glob Oncol. 2019 Jan;5:1-7. doi: 10.1200/JGO.18.00157.
9
Cancer of the cervix uteri.子宫颈癌。
Int J Gynaecol Obstet. 2018 Oct;143 Suppl 2:22-36. doi: 10.1002/ijgo.12611.
10
Cisplatin Chemoradiotherapy vs Radiotherapy in FIGO Stage IIIB Squamous Cell Carcinoma of the Uterine Cervix: A Randomized Clinical Trial.顺铂化疗联合放疗与单纯放疗治疗 FIGO 分期为 IIIB 期的子宫颈鳞状细胞癌的随机临床试验。
JAMA Oncol. 2018 Apr 1;4(4):506-513. doi: 10.1001/jamaoncol.2017.5179.